Brainsway Ltd.
Develops noninvasive neurostimulation treatments for mental health and addiction.
BWAY | TA
Overview
Corporate Details
- ISIN(s):
- IL0011007189
- LEI:
- Country:
- Israel
- Address:
- 16 Hartum St, 9777516 Har Hotzvim, Jerusalem
- Website:
- https://www.brainsway.com/
- Sector:
- Manufacturing
Description
Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-19 08:59 |
FORM F-3 - SHELF REGISTRATION
|
English | 366.6 KB | ||
| 2021-09-19 08:59 |
FORM F-3 - SHELF REGISTRATION
|
English | 35.9 KB | ||
| 2021-08-18 16:29 |
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depres…
|
English | 127.6 KB | ||
| 2021-08-18 16:29 |
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depres…
|
English | 36.1 KB | ||
| 2021-08-11 16:59 |
FORM 6-K-Reports Second Quarter 2021 Financial Results
|
English | 193.6 KB | ||
| 2021-08-11 16:59 |
FORM 6-K-Reports Second Quarter 2021 Financial Results
|
English | 36.0 KB | ||
| 2021-06-18 01:58 |
FORM 20-F/A
|
Hebrew (modern) | 165.8 KB | ||
| 2021-06-18 01:58 |
FORM 20-F/A
|
English | 36.1 KB | ||
| 2021-06-03 18:45 |
Completion of Options Exchange Offer
|
English | 340.2 KB | ||
| 2021-06-03 18:45 |
Completion of Options Exchange Offer
|
English | 36.0 KB | ||
| 2021-06-03 18:43 |
SCHEDULE TO - Offer to Exchange Eligible Options for New Options - Amendment No…
|
English | 491.9 KB | ||
| 2021-06-03 18:43 |
SCHEDULE TO - Offer to Exchange Eligible Options for New Options - Amendment No…
|
English | 36.0 KB | ||
| 2021-06-02 16:59 |
Announces Positive OCD Coverage Policy by Blue Cross Blue Shield Licensee HCSC
|
English | 104.5 KB | ||
| 2021-06-02 16:59 |
Announces Positive OCD Coverage Policy by Blue Cross Blue Shield Licensee HCSC
|
English | 36.1 KB | ||
| 2021-06-01 16:59 |
Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administ…
|
English | 106.9 KB |
Automate Your Workflow. Get a real-time feed of all Brainsway Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Brainsway Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Brainsway Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
